Dorothy DeBolt, co-founder of AASK
since 1973, died on February 24, 2013.
study compared outcomes between the two approaches to BP control in 1,094 black adults with mild to moderate hypertensive CKD but without marked proteinuria.
The findings from the AASK
coupled with the results of other studies showing ACE inhibitors protect against proteinuria extend the value of these agents to patients with kidney disease of hypertension, at least to individuals who already have protein in their urine.
recruits families from all across the country to match with wait- ing children: It now has 973 children and 1,032 families in its database.
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK
the fund administrators the cash equivalent value of your husband's pension fund.
your GP to run blood tests to make sure you don't have diabetes.
The results of AASK
, like those of many other recently completed studies, show that drugs that block the renin-angiotensin system pack an extra punch for kidney protection.
to see your GP immediately and explain all of this to him.
PREVEND (Prevention of Renal and Vascular End Stage Disease) HOPE (Heart Outcomes Prevention Evaluation) AUSDIAB (Australian Diabetes, Obesity and Lifestyle Study) AASK
(African - American Study of Kidney Disease and Hypertension)
Results from AASK
and from many other recent trials have shown that these drugs work best for preserving renal function and blocking progression of proteinuria.
him to write down what he eats and send me the details of his wonder diet.